Giuseppe MichieliJun 30, 2024

#Antiviral susceptibility of #SARS-CoV-2 and #influenza viruses from 3 co-infected #pediatric #patients, Int J Infect Dis.: https://www.ijidonline.com/article/S1201-9712(24)00205-4/fulltext

SARS-CoV-2 & influenza viruses were isolated from co-infected pediatric patients. SARS-CoV-2 was susceptible to #RdRP and #3CLpro inhibitors. Influenza viruses were susceptible to #NA & #CEN inhibitors Patients treated with anti-influenza drugs did not develop severe symptoms.

Giuseppe MichieliFeb 10, 2023
#Efficacy #comparison of #3CLpro #inhibitors #ensitrelvir and #nirmatrelvir against #SARS-CoV-2 in vitro and in vivo https://academic.oup.com/jac/advance-article/doi/10.1093/jac/dkad027/7033725?rss=1
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo

AbstractObjectives. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become established in the human population, making the need to develop safe

OUP Academic